Heard a little whisper that Avexa is currently (ie mid Feb) having follow up meetings with a couple of big pharma folk. Timing is interesting. Hopefully a development/marketing deal would give shareholders another option to consider.
AVX Price at posting:
6.8¢ Sentiment: Hold Disclosure: Held